Schreck KC - Search Results

1

Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.

Schreck KC, Strowd RE, Nabors LB, Ellingson BM, Chang M, Tan SK, Abdullaev Z, Turakulov R, Aldape K, Danda N, Desideri S, Fisher J, Iacoboni M, Surakus T, Rudek MA, Bettegowda C, Grossman SA, Ye X. Schreck KC, et al. Clin Cancer Res. 2024 May 15;30(10):2048-2056. doi: 10.1158/1078-0432.CCR-23-3241. Clin Cancer Res. 2024. PMID: 38446982 Free PMC article. Clinical Trial.

2

The exon junction complex component Magoh controls brain size by regulating neural stem cell division.

Silver DL, Watkins-Chow DE, Schreck KC, Pierfelice TJ, Larson DM, Burnetti AJ, Liaw HJ, Myung K, Walsh CA, Gaiano N, Pavan WJ. Silver DL, et al. Among authors: schreck kc. Nat Neurosci. 2010 May;13(5):551-8. doi: 10.1038/nn.2527. Epub 2010 Apr 4. Nat Neurosci. 2010. PMID: 20364144 Free PMC article.

3

The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.

Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N, Eberhart CG. Schreck KC, et al. Clin Cancer Res. 2010 Dec 15;16(24):6060-70. doi: 10.1158/1078-0432.CCR-10-1624. Clin Cancer Res. 2010. PMID: 21169257 Free PMC article.

4

Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma.

Grossman SA, Schreck KC, Ballman K, Alexander B. Grossman SA, et al. Among authors: schreck kc. Neuro Oncol. 2017 Apr 1;19(4):469-474. doi: 10.1093/neuonc/nox030. Neuro Oncol. 2017. PMID: 28388713 Free PMC article. No abstract available.

5

Effect of ketogenic diets on leukocyte counts in patients with epilepsy.

Schreck KC, Lwin M, Strowd RE, Henry-Barron BJ, Blakeley JO, Cervenka MC. Schreck KC, et al. Nutr Neurosci. 2019 Jul;22(7):522-527. doi: 10.1080/1028415X.2017.1416740. Epub 2017 Dec 18. Nutr Neurosci. 2019. PMID: 29254457

6

Concurrent BRAF/MEK Inhibitors in BRAF V600-Mutant High-Grade Primary Brain Tumors.

Schreck KC, Guajardo A, Lin DDM, Eberhart CG, Grossman SA. Schreck KC, et al. J Natl Compr Canc Netw. 2018 Apr;16(4):343-347. doi: 10.6004/jnccn.2017.7052. J Natl Compr Canc Netw. 2018. PMID: 29632053

7

Role of Temozolomide in the Treatment of Cancers Involving the Central Nervous System.

Schreck KC, Grossman SA. Schreck KC, et al. Oncology (Williston Park). 2018 Nov 15;32(11):555-60, 569. Oncology (Williston Park). 2018. PMID: 30474103 Free article. Review.

8

Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.

Schreck KC, Ranjan S, Skorupan N, Bettegowda C, Eberhart CG, Ames HM, Holdhoff M. Schreck KC, et al. J Neurooncol. 2019 May;143(1):87-93. doi: 10.1007/s11060-019-03134-x. Epub 2019 Mar 12. J Neurooncol. 2019. PMID: 30864101 Free PMC article.

9

BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors.

Schreck KC, Grossman SA, Pratilas CA. Schreck KC, et al. Cancers (Basel). 2019 Aug 28;11(9):1262. doi: 10.3390/cancers11091262. Cancers (Basel). 2019. PMID: 31466300 Free PMC article. Review.

10

Cerebral Ketones Detected by 3T MR Spectroscopy in Patients with High-Grade Glioma on an Atkins-Based Diet.

Berrington A, Schreck KC, Barron BJ, Blair L, Lin DDM, Hartman AL, Kossoff E, Easter L, Whitlow CT, Jung Y, Hsu FC, Cervenka MC, Blakeley JO, Barker PB, Strowd RE. Berrington A, et al. Among authors: schreck kc. AJNR Am J Neuroradiol. 2019 Nov;40(11):1908-1915. doi: 10.3174/ajnr.A6287. Epub 2019 Oct 24. AJNR Am J Neuroradiol. 2019. PMID: 31649157 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters